Recruiting NA Lower Limb Amputation

New treatment option for Lower Limb Amputation

Official title Dual-Task Balance Training in Traumatic Lower-Limb Prosthesis Users

ClinicalTrials.gov ID: NCT07706452

What this study is testing

What it's testing
This randomized controlled trial will evaluate the effectiveness of dual-task balance training on balance, mobility, and mental health among traumatic lower-limb prosthesis users in the Gaza Strip. Participants will be randomly assigned to either an experimental group receiving dual-task balance training in addition to standard rehabilitation or a control group receiving standard rehabilitation only.
  • Time commitment: about 6 weeks
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Adults aged 18 years or older.
  • Traumatic unilateral lower-limb amputation.
  • Transtibial or transfemoral amputation level.
  • Current lower-limb prosthesis user.
  • Able to stand and walk with the prosthesis, with or without an assistive device.

You likely can't join if

  • Lower-limb amputation due to dysvascular, congenital, or non-traumatic causes.
  • Bilateral lower-limb amputation.
  • Severe cognitive impairment that prevents understanding or following study instructions.
  • Severe visual, vestibular, neurological, or musculoskeletal condition that significantly affects balance or walking independent of the amputation.
  • Unhealed residual limb wounds, severe pain, or skin problems that prevent safe prosthesis use.
  • Uncontrolled medical condition that makes participation unsafe.
See the full eligibility criteria
Who can join
  • Adults aged 18 years or older.
  • Traumatic unilateral lower-limb amputation.
  • Transtibial or transfemoral amputation level.
  • Current lower-limb prosthesis user.
  • Able to stand and walk with the prosthesis, with or without an assistive device.
  • Medically stable and able to participate in a rehabilitation training program.
  • Able to understand and follow study instructions.
  • Provides written informed consent.
What rules you out
  • Lower-limb amputation due to dysvascular, congenital, or non-traumatic causes.
  • Bilateral lower-limb amputation.
  • Severe cognitive impairment that prevents understanding or following study instructions.
  • Severe visual, vestibular, neurological, or musculoskeletal condition that significantly affects balance or walking independent of the amputation.
  • Unhealed residual limb wounds, severe pain, or skin problems that prevent safe prosthesis use.
  • Uncontrolled medical condition that makes participation unsafe.
  • Participation in another structured balance training program during the study period.

The study team makes the final eligibility decision.

Where it's taking place

  • Gaza, Gaza Strip, Palestinian Territories

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The study runs about 6 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Gaza, Gaza Strip, Palestinian Territories. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.